Search
US Media Reports: China's CXMT Embarks on Trial Production of HBM3E, Eyeing Mass Production in Weeks
1 day ago /
Read about 0 minute
Author：小编
As reported by The Information, CXMT has commenced the risk trial production phase for its HBM3E memory. By the end of this year, the company's DRAM production capacity is projected to soar to 350,000 wafers on a monthly basis. Considering its swift production capabilities, it is plausible that HBM3E could transition into mass production within the next few weeks.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
